Recorded on August 5, 2021
Clinical trials are the foundation of advancing treatment options. Understanding their importance, dispelling myths and fears about enrollment, and acknowledging disparities in access can help providers educate their patients and discuss treatment in a clinical trial as an option at any point in the patient’s cancer journey. In this episode, we welcome special guest host Leah Szumita, MS, RN, CCRN, ACNS-BC, Director of The Leukemia & Lymphoma Society’s Clinical Trial Support Center as she speaks with Lorenzo Falchi, MD, Assistant Attending, Lymphoma Service, Memorial Sloan-Kettering Cancer Center in New York City, about the importance of clinical trials, understanding patient concerns, barriers to participation and strategies to overcome these barriers, and how clinical trials have been impacted by COVID-19.
 |
Lorenzo Falchi, MD Assistant Attending Lymphoma Service Memorial Sloan-Kettering Cancer Center New York, NY |
|
Leah Szumita, MS, RN, CCRN, ACNS-BC Director, Clinical Trial Support Center The Leukemia & Lymphoma Society Rye Brook, NY |
Podcast: Play in new window | Download (Duration: 28:25 — 26.0MB)